Related Experiment Video
Updated: Jul 10, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Nosocomial pneumonia: Current etiology and impact on antimicrobial therapy
J J Gamazo, F J Candel1, J González Del Castillo
1Francisco Javier Candel, Clínical Microbiology and Infectious Diseases. Transplant Coordination and Cell Tissue Bank. IdISSC and IML Health Research Institutes. Hospital Clínico Universitario San Carlos. Associate Professor. School of Medicine. Complutense University. Madrid. Spain. franciscojavier.candel@salud.madrid.org.
Abstract:
Nosocomial pneumonia is an infection with high clinical impact and high morbimortality in which Pseudomonas aeruginosa plays a priority role, especially in the critically ill patient. Conventional antipseudomonal treatments, historically considered as standard, are currently facing important challenges due to the increase of antimicrobial resistance. In recent years, new antimicrobials have been developed with attractive sensitivity profiles and remarkable efficacy in clinical scenarios of nosocomial pneumonia including bacteremia, mechanical ventilation, infections with multidrug-resistant organisms or situations of therapeutic failure. This new evidence underscores the need to update current clinical guidelines for the antimicrobial treatment of nosocomial pneumonia, especially in the most critically ill patients.
Insights
Nosocomial pneumonia caused by Pseudomonas aeruginosa is a serious infection. New antimicrobials show promise in treating resistant strains, necessitating updated clinical guidelines for critically ill patients.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Pharmacology
Background:
- Nosocomial pneumonia poses a significant clinical challenge, with Pseudomonas aeruginosa being a primary pathogen, particularly in critically ill patients.
- Rising antimicrobial resistance compromises the effectiveness of traditional treatments for Pseudomonas aeruginosa infections.
- Emerging antimicrobial agents offer improved sensitivity and efficacy against challenging nosocomial pneumonia cases.
Purpose of the Study:
- To review the evolving landscape of antimicrobial treatments for nosocomial pneumonia.
- To highlight the role of new antimicrobials in managing Pseudomonas aeruginosa infections.
- To emphasize the need for updated clinical guidelines in light of new therapeutic options.
Main Methods:
- Literature review of recent studies on nosocomial pneumonia and Pseudomonas aeruginosa.
- Analysis of antimicrobial sensitivity profiles and clinical efficacy data.
- Evaluation of treatment outcomes in various clinical scenarios.
Main Results:
- Pseudomonas aeruginosa remains a critical pathogen in nosocomial pneumonia, especially in intensive care settings.
- Increasing antimicrobial resistance necessitates alternative treatment strategies.
- Newer antimicrobial agents demonstrate promising efficacy in complex cases, including bacteremia and multidrug-resistant infections.
Conclusions:
- Current antipseudomonal treatments face significant challenges due to resistance.
- Novel antimicrobials offer effective options for nosocomial pneumonia, including in critical care.
- Updating clinical guidelines is crucial to optimize the management of nosocomial pneumonia, particularly in severe cases.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.